Suggested remit - To appraise the clinical and cost effectiveness of cannabidiol within its marketing authorisation for adjuvant treatment of seizures associated with Dravet syndrome or Lennox-Gastaut syndrome.
Status
|
In progress
|
Process |
STA 2018
|
ID number |
1211
|
Provisional Schedule
Expected publication |
18 December 2019 |
Project Team
Project lead |
Jeremy Powell |
Email enquiries
Evidence Review Group / Assessment Group |
Kleijnen Systematic Reviews |
Consultees
Companies sponsors |
GW Pharma |
Others |
Department of Health and Social Care |
|
NHS England |
|
Welsh Government |
Patient carer groups |
Dravet Syndrome UK |
|
Epilepsy Action |
|
Epilepsy Society |
Professional groups |
Association of British Neurologists |
|
Primary Care and Community Neurology Society |
|
Royal College of Physicians |
Commentators
Associated public health groups |
Public Health England |
|
Public Health Wales |
Comparator companies |
Accord Healthcare (clobazam, topiramate) (not participating) |
|
Atnahs Pharma UK (clobazam) (not participating) |
|
Aurobindo Pharma - Milpharm (topiramate) (not participating) |
|
Biocodex (stiripentol) (not participating) |
|
Desitin Pharma (sodium valproate) (not participating) |
|
Janssen (topiramate) (not participating) |
|
Martindale Pharma (clobazam) (not participating) |
|
Mylan (topiramate) (not participating) |
|
Rosemont Pharmaceuticals (clobazam) (not participating) |
|
Sandoz (topiramate) (not participating) |
|
Sanofi (clobazam, sodium valproate) (not participating) |
|
Thame Laboratories (clobazam) (not participating) |
|
Wockhardt UK (sodium valproate) (not participating) |
|
Zentiva (sodium valproate) (not participating) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
British National Formulary |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Scottish Medicines Consortium |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
Cochrane Epilepsy Group |
Date
|
Update
|
11 November 2019 - 27 November 2019
|
Final appraisal document |
29 October 2019
|
Committee meeting: 3 |
26 September 2019
|
Committee meeting: 2 |
23 August 2019 - 16 September 2019
|
Appraisal consultation: 1 |
30 July 2019
|
Committee meeting: 1 |
14 March 2019
|
The date of the first Committee meeting has been amended to 30 July 2019. |
31 October 2018
|
Invitation to participate |
24 April 2018
|
In progress, referral |
16 January 2018 (10:00)
|
Scoping workshop (London) |
21 November 2017 - 19 December 2017
|
Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators |
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance